Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients - PubMed (original) (raw)
Multicenter Study
Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients
X Ayral et al. Osteoarthritis Cartilage. 2005 May.
Free article
Abstract
Objective: To evaluate the prevalence of synovitis in painful medial tibiofemoral knee osteoarthritis (OA) and to evaluate correlation between synovitis and the structural severity and progression of tibiofemoral cartilage damage.
Study: Multicenter, longitudinal, 1-year duration.
Patients: Primary painful knee OA (ACR criteria) of the medial tibiofemoral compartment, with pain of the signal knee on at least 30 days in the past 2 months, medial joint space width > or = 2mm, at least 10% of one cartilage surface of the medial compartment affected by superficial fibrillation or worse at baseline arthroscopy. ARTHROSCOPIC PARAMETERS: Knee arthroscopy under local anesthesia was performed and videorecorded at entry and after 1 year. Medial chondropathy was scored by using Societe Francaise d'Arthroscopie (SFA) score (0-100) and reader's overall assessment (VAS score, 100 mm). Progression of medial chondropathy was defined by a change in SFA and VAS scores over 4.5 and 8.0 mm after 1 year, respectively. Medial perimeniscal synovium was scored as normal (few translucent and slender villi, fine vascular network), reactive (proliferation of opaque villi), or inflammatory (hypervascularization and/or proliferation of hypertrophic and hyperemic villi). Medial chondropathy and synovitis were scored by a single reader blind to chronology of paired videotapes.
Results: Four hundred and twenty-two patients were enrolled (mean age: 61 years, females: 59%, body mass index: 31, mean disease duration: 4 years) and completed the 1-year study. Synovial abnormalities were present in 50% of the patients with reactive and inflammatory aspects in 29% and 21% of the patients, respectively. Patients with a reactive or inflammatory medial synovium had a more severe medial chondropathy. The worsening in medial chondropathy after 1 year was statistically more severe in the group of patients with an inflammatory perimeniscal synovial membrane at baseline compared to patients with normal and reactive aspects, with no difference between these two latter groups. The odds ratio for progression in VAS score after 1 year was 3.11 (95% CI [1.07, 5.69]) for patients with inflammatory synovium at baseline compared to patients with normal synovium.
Conclusions: This study suggests that abnormalities of the medial perimeniscal synovium are a common feature of painful medial knee OA, associated with more severe medial chondropathy. It also suggests that an inflammatory aspect of the medial perimeniscal synovium could be considered as a predictive factor of subsequent increased degradation of medial chondropathy.
Similar articles
- Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee. A multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam.
Ayral X, Mackillop N, Genant HK, Kirkpatrick J, Beaulieu A, Pippingskiöld P, Will RK, Alava S, Dougados M. Ayral X, et al. Osteoarthritis Cartilage. 2003 Mar;11(3):198-207. doi: 10.1016/s1063-4584(02)00353-9. Osteoarthritis Cartilage. 2003. PMID: 12623291 Clinical Trial. - Arthroscopic evaluation of post-traumatic patellofemoral chondropathy.
Ayral X, Ravaud P, Bonvarlet JP, Simonnet J, Lecurieux R, Nguyen M, Sauvage E, Dougados M. Ayral X, et al. J Rheumatol. 1999 May;26(5):1140-7. J Rheumatol. 1999. PMID: 10332981 - Arthroscopic evaluation of chondropathy in osteoarthritis of the knee.
Ayral X, Dougados M, Listrat V, Bonvarlet JP, Simonnet J, Amor B. Ayral X, et al. J Rheumatol. 1996 Apr;23(4):698-706. J Rheumatol. 1996. PMID: 8730130 - Diagnostic and quantitative arthroscopy: quantitative arthroscopy.
Ayral X. Ayral X. Baillieres Clin Rheumatol. 1996 Aug;10(3):477-94. doi: 10.1016/s0950-3579(96)80045-8. Baillieres Clin Rheumatol. 1996. PMID: 8876955 Review. - Synovitis in osteoarthritis: current understanding with therapeutic implications.
Mathiessen A, Conaghan PG. Mathiessen A, et al. Arthritis Res Ther. 2017 Feb 2;19(1):18. doi: 10.1186/s13075-017-1229-9. Arthritis Res Ther. 2017. PMID: 28148295 Free PMC article. Review.
Cited by
- The role of mechanosensitive ion channel Piezo1 in knee osteoarthritis inflammation.
He D, Liu X, Yang W, Guan T, Wang G. He D, et al. Channels (Austin). 2024 Dec;18(1):2393088. doi: 10.1080/19336950.2024.2393088. Epub 2024 Aug 22. Channels (Austin). 2024. PMID: 39169878 Free PMC article. Review. - Terminal sterilization influences the efficacy of an extracellular matrix-blood composite for treating posttraumatic osteoarthritis in the rat model.
Karamchedu NP, Fleming BC, Proffen BL, Sant NJ, Portilla G, Parola LR, Molino J, Murray MM. Karamchedu NP, et al. J Orthop Res. 2022 Mar;40(3):573-583. doi: 10.1002/jor.25056. Epub 2021 May 5. J Orthop Res. 2022. PMID: 33913543 Free PMC article. - Biologic agents in osteoarthritis: hopes and disappointments.
Chevalier X, Eymard F, Richette P. Chevalier X, et al. Nat Rev Rheumatol. 2013 Jul;9(7):400-10. doi: 10.1038/nrrheum.2013.44. Epub 2013 Apr 2. Nat Rev Rheumatol. 2013. PMID: 23545735 Review. - Evaluation of osteoarthritic features in peripheral joints by ultrasound imaging: A systematic review.
Molyneux P, Bowen C, Ellis R, Rome K, Frecklington M, Carroll M. Molyneux P, et al. Osteoarthr Cartil Open. 2021 Jul 16;3(3):100194. doi: 10.1016/j.ocarto.2021.100194. eCollection 2021 Sep. Osteoarthr Cartil Open. 2021. PMID: 36474810 Free PMC article. Review. - Pes Anserine Bursitis in Symptomatic Osteoarthritis Patients: A Mesotherapy Treatment Study.
Saggini R, Di Stefano A, Dodaj I, Scarcello L, Bellomo RG. Saggini R, et al. J Altern Complement Med. 2015 Aug;21(8):480-4. doi: 10.1089/acm.2015.0007. Epub 2015 Jun 17. J Altern Complement Med. 2015. PMID: 26083769 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous